Triglyceride and cardiovascular risk: A critical appraisal
Main Authors: | Awadhesh Kumar Singh, Ritu Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=4;spage=418;epage=428;aulast=Singh |
Similar Items
-
Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis
by: Awadhesh Kumar Singh, et al.
Published: (2017-01-01) -
SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins
by: Awadhesh K Singh, et al.
Published: (2019-01-01) -
Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
by: Awadhesh Kumar Singh, et al.
Published: (2020-01-01) -
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
by: Awadhesh Kumar Singh, et al.
Published: (2015-01-01) -
Heart failure hospitalization with DPP-4 inhibitors: A systematic review and meta-analysis of randomized controlled trials
by: Awadhesh Kumar Singh, et al.
Published: (2019-01-01)